Pharmafile Logo
Pharmafocus logo
Advanced Search
Syrum image

Boehringer’s Syrum Facebook game launch date released

August 22, 2012
Medical Communications Boehringer, Facebook, Syrum

Boehringer Ingelheim has announced the launch date of its social media game Syrum. John Pugh, Boehringer’s director of digital communications …

News

Allergan signs $1.5 billion deal with Molecular Partners

August 22, 2012
Research and Development, Sales and Marketing Allergan, Molecular Partners, eye diseases

Allergan has signed a deal potentially worth $1.5 billion with Molecular Partners to develop new drugs for certain eye diseases. …

News
NHS image

UK government pushes through formulary changes

August 22, 2012
Sales and Marketing CCGs, NHS, NICE, PCTs, UK, lottery, prescribing

The government has written to NHS prescribing leads telling them they must start to incorporate NICE guidance into their formularies. …

News
Doctor and computer image

UK doctors not going digital for product information

August 22, 2012
Medical Communications GPs, UK, digital, doctorsnet

A new survey has revealed that the majority of doctors in the UK are not looking online for information about …

News
screen_shot_2012-08-22_at_09

Lundbeck makes two senior appointments

August 22, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Andreas Eggert, Klaus Abel, Lundbeck

Lundbeck has appointed Andreas Eggert (pictured) as senior vice president for global product strategy, and Klaus Abel as vice president …

Appointment
Avastin image

Another NICE no for Avastin in breast cancer

August 22, 2012
Sales and Marketing NICE, avastin, breast cancer, rejection

Roche’s Avastin has been rejected once again for use in breast cancer patients.  NICE has now issued final guidance saying …

News

Pfizer’s arthritis drug delayed by FDA

August 21, 2012
Research and Development, Sales and Marketing FDA, Pfizer, tofacitinib

Pfizer says its new rheumatoid arthritis drug tofacitinib has been delayed by the FDA. Tofacitinib, an oral Janus kinase (JAK) …

News

Charity launches ‘Diabetes App Challenge’

August 21, 2012
Medical Communications apps, diabetes, digital

Diabetes UK has launched its Diabetes App Challenge for younger insulin dependent patients. The Diabetes App Challenge wants people with …

News
Whitehead image

NICE bows to industry pressure

August 21, 2012
Sales and Marketing ABPI, NICE, QALY, VBP

NICE has bowed to industry pressure and will allow independent advisors to sit on its appeals board. An appeal can …

News
screen_shot_2012-08-21_at_09

INC Research promotes Jamie Macdonald to chief executive

August 21, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing INC Research, Jamie Macdonald

Clinical research organisation INC Research has announced chief operating officer Jamie Macdonald will become the firm’s next president and chief …

Appointment
ABPI image

ABPI slams NICE International

August 20, 2012
Sales and Marketing ABPI, NICE, NICE International, Romania, hta

The ABPI has expressed concerns over the remit of NICE International and its affect on global markets. NICE International is …

News

Pharma manufacturing news in brief

August 20, 2012
Manufacturing and Production, Sales and Marketing Cambrex, GSK, Laureate, Morphotek

GlaxoSmithKline says it has shut down one of its two manufacturing facilities in India after offering all workers there early …

News
Roche image

Roche winning on Perjeta supply, but running short of Boniva

August 20, 2012
Manufacturing and Production, Sales and Marketing Boniva, Perjeta, Roche, breast cancer

Roche is getting production for its new breast cancer drug Perjeta back on track after some initial teething troubles, but …

News

Hospira hit by yet another product recall

August 20, 2012
Manufacturing and Production, Sales and Marketing Carpuject, Hospira, overdose, recall

Generic pharma company Hospira has been forced to recall another product as it works to rectify quality issues at three …

News

Claris LifeSciences gets clean bill of health from FDA

August 20, 2012
Manufacturing and Production, Sales and Marketing Claris, FDA, Pfizer, sterile

Indian drugmaker Claris LifeSciences seems to have set its house in order after manufacturing issues led the FDA to impose …

News

GSK severe asthma drug progresses to Phase III

August 20, 2012
Research and Development, Sales and Marketing Advair, GSK, Phase II, asthma, phase III

GlaxoSmithKline’s severe asthma drug mepolizumab has impressed in a mid-stage study, meaning it can now progress into Phase III testing. …

News
Takeda's Actos

Generic Actos gains FDA approval

August 20, 2012
Sales and Marketing Actos, Mylan, Ranbaxy, Takeda, diabetes, generic

Takeda’s big-selling diabetes pill Actos will have its US sales decimated after the FDA approves three copycat versions of the …

News

Euro RSCG Life UK expands account services team

August 17, 2012
Medical Communications Euro RSCG Life UK, Havas, Lucretia King

Euro RSCG Life UK, a leading healthcare communications network, is pleased to announce the appointment of Lucretia King as client …

News

Reynolds-MacKenzie appoints new leadership team

August 17, 2012
Medical Communications Reynolds-Mackenzie

Reynolds-MacKenzie has made two new senior hires and an internal promotion to help drive its UK and international operations. The …

News
McCann

IPA Best of Health 2012 Awards highlights

August 17, 2012
Medical Communications Best of Health, IPA, IPA Best of Health Awards, McCann Torre Lazur, advertising

McCann Torre Lazur and The Cement Bloc were awarded the prestigious ‘Best of Show’ awards at the 2012 IPA Best …

Feature
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026